Skip to content

The Effects and Mechanisms of Interactions Between Hepatitis B Virus and Host Genome on the Risk of Hepatocarcinogenesis

The Effects and Mechanisms of Interactions Between Hepatitis B Virus and Host Genome on the Risk of Hepatocarcinogenesis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119115
Enrollment
Unknown
Registered
2026-02-23
Start date
2023-12-23
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis B (CHB)

Interventions

Case group:NA

Sponsors

Guangzhou Eighth people's Hospital, Guangzhou Medical University, Guangzhou, China.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1. Adults aged 18 years or older; 2. Patients with liver nodules detected by imaging, or those diagnosed with liver cirrhosis; 3. Availability of at least one analyzable liver ultrasound image and laboratory test results; 4. Availability of laboratory test results obtained within a close timeframe to the imaging; 5. Complete clinical follow-up data or anticipated follow-up duration of at least 12 months every 6 months.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1. Ultrasound images and laboratory test results not meeting the minimum quality criteria for analysis; 2. Absence of contemporaneous laboratory data or clinical information; 3. Presence of other major comorbidities that may interfere with liver disease assessment; 4. History of liver transplantation or major liver surgery; 5. Unwillingness or inability to comply with follow-up procedures; 6. Patients with decompensated cirrhosis.

Design outcomes

Primary

MeasureTime frame
The prediction accuracy for the risk of HCC in patients with cirrhosis within 6 months and 1 year (measured by AUC and time-dependent AUC).;

Secondary

MeasureTime frame
Patients whose cirrhosis eventually progressed to HCC, including tumor burden at diagnosis (measured by maximum tumor diameter and number of tumors) and treatment modality ;

Countries

China

Contacts

Public ContactJian-Ping Li

Department of Hepatology, Guangzhou Eighth people's Hospital, Guangzhou Medical University, Guangzhou, China.

gz8hljp@126.com+86 135 7030 3667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026